Medication Abortion

Management of retained products of conception and a comparison of buccal and vaginal misoprostol for medication abortion, contraceptive values and preferences of adolescents and young adults, and more.

Novel ulipristal-releasing copper IUD, internal medicine physicians’ provision of medication abortion in a primary care setting, analysis of contraceptive decision aids for adolescents and young adults, and more.

Provision of medication abortion via telehealth, updated CDC treatment guidelines for sexually-transmitted infections, barriers to IUD and implant access for adolescent and young adult patients, and more.

In-clinic vs pharmacy provision of medication abortion, cost barriers to contraceptive access among community college students, opportunities for PrEP counseling for adolescent and young adults, and more.

Pre-treatment with mifepristone for pain management in first-trimester surgical abortion care, high patient and provider satisfaction with telemedicine contraceptive counseling, an update to the CDC’s recommendation on self-administered DMPA-SC, and more.

Honest answers—supported by facts and research—and patient resources too!

Public health benefits of widespread HPV vaccination, potential for IUDs to be placed as emergency contraception 6-14 days after unprotected vaginal sex, etonogestrel implants to help with pelvic pain, and more.

Importance of trans-inclusive clinics and accessible education on evidence-based self-managed abortion techniques for gender-expansive individuals, an update to the CDC’s treatment guidelines for gonococcal infection, the effects of stigma and barriers to access on abortion method preference, and more.